Jason Amello
CIK 1451805 · Chief Financial Officer · last filed 2026-01-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.86M
Companies
7
Total Filings
35
Lifetime Open-Market Net
-$460.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TCRX | Chief Financial Officer | — | $0.91 | — | $0 | 3 | 2026-01-22 |
| CADL | Chief Financial Officer | 202,009 | $8.56 | $1.73M | $10.0K | 6 | 2023-11-30 |
| Acer Therapeutics Inc. (ACER) Delisted | Director | — | $0.66 | — | $0 | 5 | 2023-03-16 |
| AKBA | SVP, CFO & Treasurer | 144,642 | $0.92 | $133.7K | $20.5K | 11 | 2020-03-02 |
| Acer Therapeutics Inc. (ACERW) Delisted | Director | — | — | — | $0 | 1 | 2017-10-06 |
| Alaunos Therapeutics, Inc. (ZIOP) Delisted | Executive Vice President & CFO | 22,377 | $0.87 | $19.4K | $0 | 4 | 2013-05-14 |
| GENZYME CORP (GENZ) Delisted | CorpContrllr,ChiefAccntOfficer | 5,005 | — | — | -$491.1K | 5 | 2011-04-06 |
Recent Filings · Page 2 of 4
35 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-19 | Acer Therapeutics Inc. (ACER) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-20 | Acer Therapeutics Inc. (ACER) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-02 | AKBA | Mixed | +23,024 | -$60.7K | EDGAR |
| 2020-01-03 | Acer Therapeutics Inc. (ACER) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-04-12 | AKBA | Disp (D) | −13,148 | -$101.2K | EDGAR |
| 2019-03-05 | AKBA | Grant (A) | +65,000 | $0 | EDGAR |
| 2019-02-05 | Acer Therapeutics Inc. (ACER) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-12-13 | AKBA | Tax (F) | −22,235 | -$198.8K | EDGAR |
| 2018-03-02 | AKBA | Grant (A) | +19,500 | $0 | EDGAR |
| 2017-10-06 | Acer Therapeutics Inc. (ACERW) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.